199739-10-1

199739-10-1 structure

Name: Paliperidone Palmitate
Chemical Name: [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate
CAS Number: 199739-10-1
Molecular Formula: C₃₉H₅₇FN₄O₄
Molecular Weight: 664.893
Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
Create Date: 2018-02-18 08:00:00
Modify Date: 2024-01-06 17:17:18
Paliperidone palmitate (9-Hydroxyrisperidone palmitate), an atypical long-acting antipsychotic agent, is an ester prodrug of Paliperidone. Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class. Paliperidone palmitate shows efficacy against schizophrenia[1].

Name	[3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate
Synonyms	3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido-[1,2-a]pyrimidin-4-one palmitate ester 9-Hydroxyrisperidone palmitate Xeplion PALPERIDONE PALMITATE UNII-R8P8USM8FR Paliperidone Palmitate Invega Sustenna Paliperidone Palmitate [USAN] 3-[2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one palmitate ester Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl palmitate

Description	Paliperidone palmitate (9-Hydroxyrisperidone palmitate), an atypical long-acting antipsychotic agent, is an ester prodrug of Paliperidone. Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class. Paliperidone palmitate shows efficacy against schizophrenia[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor
Target	5-HT2A Receptor D2 Receptor
References	[1]. Kwon JS, et al. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics. Int Clin Psychopharmacol. 2015;30(6):320-328.

1415488-05-9

84163-13-3

~77%

199739-10-1

Literature: WO2012/164582 A1, ; Page/Page column 11-12 ;

623-65-4

144598-75-4

~90%

199739-10-1

Literature: WO2009/89076 A2, ; Page/Page column 15; 29 ;

57-10-3

144598-75-4

~81%

199739-10-1

Literature: WO2009/89076 A2, ; Page/Page column 28 ;

144598-75-4

112-67-4

~55%

199739-10-1

Literature: WO2009/89076 A2, ; Page/Page column 25-26 ;

1172995-09-3

112-67-4

~10%

199739-10-1

Literature: WO2009/89076 A2, ; Page/Page column 9; 26 ;

57-10-3

199739-10-1

Literature: WO2012/164582 A1, ;

130049-82-0

199739-10-1

Literature: WO2012/164582 A1, ;